Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118672552 | 11867255 | 2 | F | 2005 | 20160810 | 20151224 | 20160818 | EXP | US-ASTRAZENECA-2012SE74544 | ASTRAZENECA | 54.00 | YR | F | Y | 83.90000 | KG | 20160819 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118672552 | 11867255 | 1 | PS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | U | U | 21366 | TABLET | ||||||||
| 118672552 | 11867255 | 2 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 5.0MG UNKNOWN | U | U | 21366 | 5 | MG | TABLET | |||||
| 118672552 | 11867255 | 3 | C | LOVASTATIN. | LOVASTATIN | 1 | 10.0MG UNKNOWN | 0 | 10 | MG | TABLET | ||||||||
| 118672552 | 11867255 | 4 | C | GLIMEPIRIDE. | GLIMEPIRIDE | 1 | 2.0MG UNKNOWN | 0 | 2 | MG | TABLET | ||||||||
| 118672552 | 11867255 | 5 | C | IBUPROFEN. | IBUPROFEN | 1 | 600.0MG UNKNOWN | 0 | 600 | MG | |||||||||
| 118672552 | 11867255 | 6 | C | FLUOXETINE | FLUOXETINE HYDROCHLORIDE | 1 | 20.0MG UNKNOWN | 0 | 20 | MG | CAPSULE | ||||||||
| 118672552 | 11867255 | 7 | C | ASPIRIN. | ASPIRIN | 1 | 81.0MG UNKNOWN | 0 | 81 | MG | TABLET | ||||||||
| 118672552 | 11867255 | 8 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 88.0UG UNKNOWN | 0 | 88 | UG | TABLET | ||||||||
| 118672552 | 11867255 | 9 | C | LIVALO | PITAVASTATIN CALCIUM | 1 | 0 | TABLET | |||||||||||
| 118672552 | 11867255 | 10 | C | JANUMET | METFORMIN HYDROCHLORIDESITAGLIPTIN PHOSPHATE | 1 | 0 | TABLET | |||||||||||
| 118672552 | 11867255 | 11 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 0 | ||||||||||||
| 118672552 | 11867255 | 12 | C | ENALAPRIL MALEATE. | ENALAPRIL MALEATE | 1 | 0 | TABLET | |||||||||||
| 118672552 | 11867255 | 13 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 118672552 | 11867255 | 14 | C | LOVASTATIN. | LOVASTATIN | 1 | 0 | TABLET | |||||||||||
| 118672552 | 11867255 | 15 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | 0 | ||||||||||||
| 118672552 | 11867255 | 16 | C | LOVASTATIN. | LOVASTATIN | 1 | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118672552 | 11867255 | 1 | Blood cholesterol increased |
| 118672552 | 11867255 | 2 | Blood cholesterol increased |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118672552 | 11867255 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118672552 | 11867255 | Arthritis | |
| 118672552 | 11867255 | Back disorder | |
| 118672552 | 11867255 | Hypertension | |
| 118672552 | 11867255 | Intervertebral disc disorder | |
| 118672552 | 11867255 | Spinal cord disorder | |
| 118672552 | 11867255 | Type 2 diabetes mellitus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118672552 | 11867255 | 1 | 2003 | 0 | ||
| 118672552 | 11867255 | 2 | 20111221 | 0 | ||
| 118672552 | 11867255 | 3 | 2003 | 0 | ||
| 118672552 | 11867255 | 4 | 2003 | 0 | ||
| 118672552 | 11867255 | 5 | 2003 | 0 | ||
| 118672552 | 11867255 | 6 | 2003 | 0 | ||
| 118672552 | 11867255 | 7 | 2003 | 0 | ||
| 118672552 | 11867255 | 8 | 20120416 | 0 | ||
| 118672552 | 11867255 | 9 | 20160627 | 0 | ||
| 118672552 | 11867255 | 10 | 20160614 | 0 | ||
| 118672552 | 11867255 | 12 | 20150119 | 0 | ||
| 118672552 | 11867255 | 14 | 20150607 | 0 | ||
| 118672552 | 11867255 | 16 | 20140617 | 0 |